Delaware Crossing Investor Group Overview

  • Investor Type
  • Angel Group

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 74

  • Portfolio
  • 22

  • Exits
  • 31

Exits

Delaware Crossing Investor Group General Information

Company Description

Delaware Crossing Investor Group is a network of former and current executives and entrepreneurs who provide counsel and capital to early-stage and growing companies. The firm is a membership organization of investors who manage the investment process and serve as the board of directors of portfolio companies. The firm is based in Warrington, Pennsylvania, and was founded in 2005.

Business Details

Year Founded
2005
Investor Status
Actively Seeking New Investments
Trade Association
Angel Capital Association (ACA)
Primary Investor Type
Angel Group
Corporate Office
  • 2700 Kelly Road
  • Suite 300
  • Warrington, PA 18976
  • United States
+1 (215)

Delaware Crossing Investor Group Investments (74)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
KaloCyte 02-Jun-2025 Later Stage VC Biotechnology Pre-Clinical Trials
Vytala 19-Sep-2024 Other Pharmaceuticals and Biotechnology Generating Revenue
Measure Studio 21-Apr-2023 Business/Productivity Software Generating Revenue
Gilson (Recreational Goods) 03-Oct-2022 Recreational Goods Generating Revenue
SunRay Scientific 08-Sep-2022 Industrial Supplies and Parts Generating Revenue
Medcura 12-Aug-2021 Surgical Devices Product Development
Myota 10-Jun-2021 Network Management Software Generating Revenue
Strados Labs 01-Nov-2020 Monitoring Equipment Generating Revenue
Medcura 21-Sep-2020 Later Stage VC Surgical Devices Product Development
Pledge It 09-Jul-2020 Seed Round Other Financial Services Generating Revenue
You’re viewing 10 of 74 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Delaware Crossing Investor Group Exits (31)

Company Name Exit Date Exit Type Exit Size
Grassroots Unwired 01-Feb-2026 Secondary Transaction - Private
OnlySky 01-Feb-2026
Tobly 01-Feb-2026
MMGuardian 01-Oct-2023
Holganix 01-Jul-2023
Hulafrog 12-Jan-2023
Lia Diagnostics 13-Oct-2022
Starr Life Sciences 01-Nov-2021
Immunome (acquired in 2023) 02-Oct-2020 IPO
Squareknot 01-Jul-2020 Out of Business
You’re viewing 10 of 31 exits. Get the full list »

Delaware Crossing Investor Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Delaware Crossing Investor Group Co-Investors (35)

Name With Exits Lead Partner Series Industry
Jumpstart NJ Angel Network 2 Series chart Industry bar
Robin Hood Ventures Series chart Industry bar
Golden Seeds Series chart Industry bar
Tech Council Ventures Series chart Industry bar
Ulu Ventures Series chart Industry bar
You’re viewing 5 of 35 co-investors. Get the full list »

Delaware Crossing Investor Group FAQs

  • What is Delaware Crossing Investor Group?

    Delaware Crossing Investor Group is a network of former and current executives and entrepreneurs who provide counsel and capital to early-stage and growing companies.

  • When was Delaware Crossing Investor Group founded?

    Delaware Crossing Investor Group was founded in 2005.

  • Where is Delaware Crossing Investor Group headquartered?

    Delaware Crossing Investor Group is headquartered in Warrington, PA.

  • How many investments has Delaware Crossing Investor Group made?

    Delaware Crossing Investor Group has made 74 investments.

  • What has Delaware Crossing Investor Group invested in?

    Delaware Crossing Investor Group has made numerous investments in companies like KaloCyte, Vytala, and Measure Studio within the Biotechnology, Pharmaceuticals and Biotechnology, and Business/Productivity Software industries.

  • What has Delaware Crossing Investor Group invested in recently?

    Delaware Crossing Investor Group's latest investment was on 02-Jun-2025 in KaloCyte, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process